NCT06653621View on ClinicalTrials.gov

Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Knee ArthropathyKnee Arthritis
Interventions
DRUG

Bupivacaine liposome

Subjects receive liposomal bupivacaine as a regional anesthetic for femoral triangle block or adductor block under ultrasound guidance.

PROCEDURE

Nerve block mode : adductor block

Subjects receive liposomal bupivacaine or bupivacaine as a regional anesthetic for adductor block under ultrasound guidance.

DRUG

Bupivacaine

Subjects receive bupivacaine as a regional anesthetic for femoral triangle block or adductor block under ultrasound guidance.

PROCEDURE

Nerve block mode: femoral triangle block

Subjects receive liposomal bupivacaine or bupivacaine as a regional anesthetic for femoral triangle block under ultrasound guidance.

Trial Locations (1)

430030

Lingli DENG, Wuhan

All Listed Sponsors
lead

Huazhong University of Science and Technology

OTHER

NCT06653621 - Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement | Biotech Hunter | Biotech Hunter